Jim Kim, MD
Transplant Surgery · Los Angeles, CANPI 1174602817
Payments from drug & device makers
What this record shows
This record is dominated by education: $4,665 of the $5,985 with a category attached, or 77.9%. Intuitive Surgical accounts for 85.2% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $5,006 and has fallen 94.9% since, to $254 in 2025.
Across 25 payments — averaging $239.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- Surgical Specialties Corporation (US), Inc. (dba Corza Medical)$305
- Medtronic$249
- Sanofi-aventis U.S. LLC$149
- Baxter Healthcare$58
- Stryker$43
- plus $82 from 3 others
What the payments were for
- Food & beverage$1,32122%
- Education$4,66578%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 11 | $5,100 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 2 | $305 |
| Medtronic(2 entities) | 6 | $249 |
| Sanofi-aventis U.S. LLC | 1 | $149 |
| Baxter Healthcare | 1 | $58 |
| Stryker | 1 | $43 |
| Amgen | 1 | $35 |
| Genentech USA, Inc. | 1 | $28 |
| Merck | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$4,500
- Da Vinci Surgical System$331
- THYMOGLOBULIN$149
- RESTORE$107
How this compares
$5,985 in reported general payments places this provider in the 75th percentile of 56 transplant surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant surgery in Los Angeles
- Yuri GenykLos Angeles$35K
- Navpreet KaurLos Angeles$19K
- Gerald LipshutzLos Angeles$16K
- Mohd SheikhLos Angeles$9K
- Fady KaldasLos Angeles$7K
- Aaron AhearnLos Angeles$5K
- Juliet EmamaulleeLos Angeles$4K
- Linda SherLos Angeles$3K
- Douglas FarmerLos Angeles$3K
- Kambiz EtesamiLos Angeles$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.